Vir Biotechnology Announces Initiation of Phase 1 Clinical Trial to Evaluate a Novel Vaccine Platform

NEXT STORY
Outlook on the Surgical Site Infection Control Global Market to 2028 – Impact Analysis of COVID-19
PREV STORY
Kura Oncology to Present at J.P. Morgan Healthcare Conference
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Vir Biotechnology to Provide Pipeline Update at 38th Annual J.P. Morgan Healthcare Conference

author_avatar
NASDAQ Market News

Curetis Reports Results of the Annual General Meeting Held on June 21, 2018

Curetis Reports Results of the Annual General Meeting Held on June 21, 2018 - ...

author_avatar
NASDAQ Market News

Tarsus Pharmaceuticals, Inc. Announces FDA Acceptance of Investigational New Drug Application for TP-05 for Lyme Disease Prevention

author_avatar
NASDAQ Market News